Biotechnology
The Biotechnology industry has a total of 667 stocks, with a combined market cap of $1,537.17 billion and total revenue of $121.44 billion.
Market Cap
1,537.17B
Revenue
121.44B
Profits
-33.25B
PE Ratio
n/a
Profit Margin
-27.38%
Dividend Yield
0.02%
667 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 575.53B | -0.88% | 3,037,416 | 35.35B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 127.80B | 0.61% | 773,736 | 10.19B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 116.89B | 1.36% | 375,292 | 13.10B |
| 4 | MRNA | Moderna, Inc. | 46.80B | 1.42% | 1,872,398 | 5.15B |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.71B | -1.28% | 510,160 | 2.00B |
| 6 | ARGX | argenx SE | 29.57B | 1.67% | 708,108 | 38.60M |
| 7 | BNTX | BioNTech SE | 20.43B | 1.49% | 264,743 | 2.97B |
| 8 | GMAB | Genmab A/S | 18.49B | 0.89% | 608,304 | 2.57B |
| 9 | BGNE | BeiGene, Ltd. | 16.92B | -0.45% | 100,268 | 2.76B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 16.06B | -1.17% | 1,019,436 | 2.47B |
| 11 | INCY | Incyte Corporation | 15.43B | 0.06% | 2,123,013 | 3.77B |
| 12 | UTHR | United Therapeutics Corporation | 15.01B | 0.55% | 279,845 | 2.50B |
| 13 | SRPT | Sarepta Therapeutics, Inc. | 13.63B | -2.25% | 913,500 | 1.40B |
| 14 | RPRX | Royalty Pharma plc | 13.02B | 0.38% | 1,811,836 | 2.24B |
| 15 | TECH | Bio-Techne Corporation | 12.70B | 2.45% | 907,553 | 1.15B |
| 16 | INSM | Insmed Incorporated | 12.02B | 0.05% | 1,391,865 | 315.49M |
| 17 | LEGN | Legend Biotech Corporation | 10.32B | -4.28% | 979,041 | 342.80M |
| 18 | PCVX | Vaxcyte, Inc. | 9.14B | 0.48% | 515,538 | - |
| 19 | CERE | Cerevel Therapeutics Holdings, Inc. | 8.13B | 0.50% | 1,945,997 | - |
| 20 | SMMT | Summit Therapeutics Inc. | 8.11B | 10.10% | 3,187,903 | - |
| 21 | ROIV | Roivant Sciences Ltd. | 7.98B | 0.56% | 3,488,884 | 124.80M |
| 22 | RVMD | Revolution Medicines, Inc. | 7.66B | 1.93% | 1,071,314 | 4.57M |
| 23 | ASND | Ascendis Pharma A/S | 7.57B | -0.47% | 172,279 | 357.63M |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 7.51B | -0.79% | 693,919 | 776.62M |
| 25 | VKTX | Viking Therapeutics, Inc. | 7.28B | 2.01% | 9,115,922 | - |
| 26 | HALO | Halozyme Therapeutics, Inc. | 7.16B | 0.46% | 741,333 | 862.99M |
| 27 | JAZZ | Jazz Pharmaceuticals plc | 7.04B | 1.85% | 635,737 | 3.84B |
| 28 | BPMC | Blueprint Medicines Corporation | 7.02B | -1.32% | 427,469 | 282.21M |
| 29 | CYTK | Cytokinetics, Incorporated | 6.99B | 2.03% | 1,114,569 | 3.75M |
| 30 | EXEL | Exelixis, Inc. | 6.81B | 1.87% | 1,693,631 | 1.85B |
| 31 | KRYS | Krystal Biotech, Inc. | 6.10B | 1.41% | 222,619 | 95.95M |
| 32 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.06B | 0.36% | 165,091 | - |
| 33 | NUVL | Nuvalent, Inc. | 5.27B | 2.08% | 148,342 | - |
| 34 | BBIO | BridgeBio Pharma, Inc. | 5.06B | 1.31% | 851,638 | 218.60M |
| 35 | CRSP | CRISPR Therapeutics AG | 4.92B | 0.61% | 865,386 | 271.71M |
| 36 | APLS | Apellis Pharmaceuticals, Inc. | 4.82B | 2.24% | 1,151,794 | 524.07M |
| 37 | RNA | Avidity Biosciences, Inc. | 4.60B | 7.65% | 986,739 | 10.87M |
| 38 | DYN | Dyne Therapeutics, Inc. | 4.36B | 4.29% | 912,089 | - |
| 39 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.29B | 1.91% | 528,566 | 1.97M |
| 40 | IMVT | Immunovant, Inc. | 4.25B | 4.68% | 900,305 | - |
| 41 | AXSM | Axsome Therapeutics, Inc. | 4.11B | 0.64% | 248,845 | 251.02M |
| 42 | RARE | Ultragenyx Pharmaceutical Inc. | 4.06B | -0.44% | 591,769 | 442.59M |
| 43 | IBRX | ImmunityBio, Inc. | 3.88B | 2.19% | 1,689,820 | 302.00K |
| 44 | CORT | Corcept Therapeutics Incorporated | 3.71B | 2.09% | 824,080 | 523.53M |
| 45 | MRUS | Merus N.V. | 3.65B | -0.24% | 257,130 | 38.34M |
| 46 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.64B | 2.41% | 755,218 | - |
| 47 | IDYA | IDEAYA Biosciences, Inc. | 3.56B | 0.24% | 590,954 | 15.50M |
| 48 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.50B | -2.59% | 817,748 | 35.47M |
| 49 | ACLX | Arcellx, Inc. | 3.45B | 2.74% | 255,807 | 131.66M |
| 50 | DNLI | Denali Therapeutics Inc. | 3.44B | 0.04% | 510,117 | 295.39M |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 3.32B | 0.25% | 203,137 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 3.18B | 2.93% | 1,952,211 | 289.33M |
| 53 | ACAD | ACADIA Pharmaceuticals Inc. | 3.16B | 3.18% | 2,288,954 | 813.81M |
| 54 | ADMA | ADMA Biologics, Inc. | 3.05B | 0.61% | 2,710,148 | 283.18M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 3.02B | -0.78% | 2,956,610 | 423.49M |
| 56 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.99B | -1.13% | 281,528 | 91.93M |
| 57 | CLDX | Celldex Therapeutics, Inc. | 2.94B | 1.60% | 1,036,058 | 6.07M |
| 58 | APGE | Apogee Therapeutics, Inc. | 2.92B | 2.65% | 332,716 | - |
| 59 | MORF | Morphic Holding, Inc. | 2.83B | -0.11% | 1,401,984 | - |
| 60 | SWTX | SpringWorks Therapeutics, Inc. | 2.82B | 3.17% | 501,228 | 26.45M |
| 61 | MLTX | MoonLake Immunotherapeutics | 2.81B | -0.31% | 80,502 | - |
| 62 | MOR | MorphoSys AG | 2.77B | 0.22% | 15,562 | 264.75M |
| 63 | GERN | Geron Corporation | 2.76B | 8.62% | 12,613,532 | 520.00K |
| 64 | KYMR | Kymera Therapeutics, Inc. | 2.73B | 1.14% | 381,911 | 79.41M |
| 65 | AGIO | Agios Pharmaceuticals, Inc. | 2.73B | -0.93% | 333,773 | 29.40M |
| 66 | BEAM | Beam Therapeutics Inc. | 2.73B | 3.02% | 1,068,336 | 360.91M |
| 67 | PTCT | PTC Therapeutics, Inc. | 2.61B | 1.55% | 373,040 | 927.56M |
| 68 | IOVA | Iovance Biotherapeutics, Inc. | 2.59B | -1.91% | 6,447,987 | 1.90M |
| 69 | NTLA | Intellia Therapeutics, Inc. | 2.56B | 0.30% | 1,172,572 | 52.60M |
| 70 | VCEL | Vericel Corporation | 2.54B | 1.20% | 241,611 | 207.78M |
| 71 | FTRE | Fortrea Holdings Inc. | 2.41B | 2.67% | 953,408 | 3.01B |
| 72 | NVAX | Novavax, Inc. | 2.40B | 2.64% | 7,060,316 | 996.61M |
| 73 | PTGX | Protagonist Therapeutics, Inc. | 2.36B | -3.10% | 740,216 | 314.95M |
| 74 | RCKT | Rocket Pharmaceuticals, Inc. | 2.30B | -2.13% | 786,682 | - |
| 75 | JANX | Janux Therapeutics, Inc. | 2.28B | 2.88% | 410,223 | 7.29M |
| 76 | GPCR | Structure Therapeutics Inc. | 2.20B | 0.89% | 570,331 | - |
| 77 | CGON | CG Oncology, Inc. | 2.20B | 0.24% | 576,166 | 539.00K |
| 78 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | 3.73% | 2,917,339 | 46.24M |
| 79 | SNDX | Syndax Pharmaceuticals, Inc. | 2.08B | -0.57% | 412,545 | - |
| 80 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.08B | 1.27% | 614,700 | 411.35M |
| 81 | NMRA | Neumora Therapeutics, Inc. | 2.06B | 3.95% | 371,020 | - |
| 82 | MIRM | Mirum Pharmaceuticals, Inc. | 2.04B | 7.33% | 2,396,333 | 224.00M |
| 83 | ARVN | Arvinas, Inc. | 2.03B | 0.44% | 392,645 | 71.30M |
| 84 | VERA | Vera Therapeutics, Inc. | 2.01B | -0.38% | 416,859 | - |
| 85 | IMCR | Immunocore Holdings plc | 2.01B | -0.05% | 158,613 | 264.25M |
| 86 | AKRO | Akero Therapeutics, Inc. | 1.94B | -0.71% | 412,324 | - |
| 87 | HRMY | Harmony Biosciences Holdings, Inc. | 1.93B | 1.86% | 269,815 | 617.51M |
| 88 | LGND | Ligand Pharmaceuticals Incorporated | 1.92B | 1.07% | 85,413 | 118.31M |
| 89 | KROS | Keros Therapeutics, Inc. | 1.89B | 4.04% | 894,099 | 234.00K |
| 90 | ZLAB | Zai Lab Limited | 1.87B | -0.05% | 659,442 | 291.07M |
| 91 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.86B | 0.81% | 392,861 | 338.93M |
| 92 | GLPG | Galapagos NV | 1.81B | 0.33% | 51,940 | - |
| 93 | VRNA | Verona Pharma plc | 1.78B | 2.62% | 614,901 | - |
| 94 | EWTX | Edgewise Therapeutics, Inc. | 1.77B | 1.33% | 996,837 | - |
| 95 | SLNO | Soleno Therapeutics, Inc. | 1.77B | 3.26% | 201,368 | - |
| 96 | NAMS | NewAmsterdam Pharma Company N.V. | 1.70B | 0.75% | 63,480 | - |
| 97 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.62B | 3.97% | 2,282,084 | 355.40M |
| 98 | KURA | Kura Oncology, Inc. | 1.61B | 1.49% | 438,420 | - |
| 99 | SYRE | Spyre Therapeutics, Inc. | 1.60B | 4.52% | 355,035 | 688.00K |
| 100 | MNKD | MannKind Corporation | 1.59B | 0.86% | 1,908,093 | 224.60M |
| 101 | BLTE | Belite Bio, Inc | 1.46B | 1.63% | 4,374 | - |
| 102 | VIR | Vir Biotechnology, Inc. | 1.46B | 0.38% | 586,937 | 79.60M |
| 103 | LBPH | Longboard Pharmaceuticals, Inc. | 1.45B | 4.41% | 584,165 | - |
| 104 | RCUS | Arcus Biosciences, Inc. | 1.44B | 5.54% | 433,942 | 237.00M |
| 105 | SANA | Sana Biotechnology, Inc. | 1.42B | 5.79% | 1,335,815 | - |
| 106 | NRIX | Nurix Therapeutics, Inc. | 1.41B | 4.28% | 590,599 | 62.30M |
| 107 | DAWN | Day One Biopharmaceuticals, Inc. | 1.40B | 0.94% | 473,199 | - |
| 108 | IRON | Disc Medicine, Inc. | 1.35B | 3.98% | 207,342 | - |
| 109 | XNCR | Xencor, Inc. | 1.33B | 1.79% | 416,404 | 162.18M |
| 110 | ARDX | Ardelyx, Inc. | 1.31B | 2.37% | 3,921,599 | 159.11M |
| 111 | PRTA | Prothena Corporation plc | 1.31B | -1.45% | 309,077 | 89.25M |
| 112 | OCUL | Ocular Therapeutix, Inc. | 1.31B | 1.81% | 799,092 | 59.84M |
| 113 | ELVN | Enliven Therapeutics, Inc. | 1.28B | 9.15% | 199,711 | - |
| 114 | GYRE | Gyre Therapeutics, Inc. | 1.28B | 0.27% | 31,730 | 140.62M |
| 115 | IMTX | Immatics N.V. | 1.27B | -0.73% | 297,458 | 80.95M |
| 116 | AUTL | Autolus Therapeutics plc | 1.24B | 1.52% | 616,439 | 10.50M |
| 117 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.22B | 7.64% | 1,239,705 | 274.10M |
| 118 | RLAY | Relay Therapeutics, Inc. | 1.19B | -1.32% | 797,564 | 35.33M |
| 119 | ARQT | Arcutis Biotherapeutics, Inc. | 1.17B | -0.30% | 1,458,027 | 106.39M |
| 120 | CGEM | Cullinan Oncology, Inc. | 1.16B | 1.26% | 565,857 | - |
| 121 | INVA | Innoviva, Inc. | 1.16B | 1.98% | 478,679 | 311.59M |
| 122 | MDXG | MiMedx Group, Inc. | 1.15B | 0.65% | 627,403 | 334.51M |
| 123 | CNTA | Centessa Pharmaceuticals plc | 1.08B | 4.76% | 446,635 | 6.85M |
| 124 | SPRY | ARS Pharmaceuticals, Inc. | 1.06B | -1.88% | 578,592 | 10.00K |
| 125 | VRDN | Viridian Therapeutics, Inc. | 1.06B | 1.96% | 900,035 | 288.00K |
| 126 | TYRA | Tyra Biosciences, Inc. | 1.05B | -1.28% | 168,942 | - |
| 127 | TNGX | Tango Therapeutics, Inc. | 1.04B | -1.02% | 802,365 | 37.23M |
| 128 | CALT | Calliditas Therapeutics AB (publ) | 1.02B | 0.13% | 3,518 | 119.73M |
| 129 | ANAB | AnaptysBio, Inc. | 1.01B | -0.46% | 282,698 | 22.96M |
| 130 | BCYC | Bicycle Therapeutics plc | 1.01B | 0.29% | 79,988 | 41.61M |
| 131 | IMNM | Immunome, Inc. | 990.09M | 2.99% | 688,149 | 12.68M |
| 132 | PRAX | Praxis Precision Medicines, Inc. | 986.95M | 0.26% | 145,590 | 2.20M |
| 133 | SLN | Silence Therapeutics plc | 977.63M | -0.14% | 250,791 | 33.86M |
| 134 | ABCL | AbCellera Biologics Inc. | 958.62M | 5.16% | 692,613 | 35.79M |
| 135 | FDMT | 4D Molecular Therapeutics, Inc. | 948.76M | -0.92% | 680,153 | 20.45M |
| 136 | HUMA | Humacyte, Inc. | 945.53M | -2.58% | 3,849,251 | - |
| 137 | TARS | Tarsus Pharmaceuticals, Inc. | 944.92M | -11.44% | 1,920,648 | 42.56M |
| 138 | MESO | Mesoblast Limited | 939.79M | -0.27% | 89,183 | 7.25M |
| 139 | PHVS | Pharvaris N.V. | 936.41M | -0.23% | 35,619 | - |
| 140 | NUVB | Nuvation Bio Inc. | 926.28M | 1.36% | 1,001,826 | - |
| 141 | COGT | Cogent Biosciences, Inc. | 910.24M | 3.25% | 417,600 | - |
| 142 | ETNB | 89bio, Inc. | 909.07M | -4.35% | 597,480 | - |
| 143 | LQDA | Liquidia Corporation | 888.69M | 1.48% | 424,019 | 15.97M |
| 144 | LXRX | Lexicon Pharmaceuticals, Inc. | 863.97M | 2.58% | 3,124,961 | 2.31M |
| 145 | OLMA | Olema Pharmaceuticals, Inc. | 863.06M | 5.04% | 533,996 | - |
| 146 | ERAS | Erasca, Inc. | 852.29M | 0.31% | 1,360,708 | - |
| 147 | DNTH | Dianthus Therapeutics, Inc. | 850.26M | 3.13% | 232,925 | 2.26M |
| 148 | CVAC | CureVac N.V. | 834.42M | 2.20% | 333,142 | 64.13M |
| 149 | STOK | Stoke Therapeutics, Inc. | 826.63M | 8.93% | 900,700 | 7.85M |
| 150 | DNA | Ginkgo Bioworks Holdings, Inc. | 822.89M | 9.98% | 42,957,152 | 208.70M |
| 151 | CRGX | CARGO Therapeutics, Inc. | 818.63M | 0.85% | 120,593 | - |
| 152 | AUPH | Aurinia Pharmaceuticals Inc. | 812.35M | 1.43% | 984,430 | 191.41M |
| 153 | PLRX | Pliant Therapeutics, Inc. | 806.56M | 0.45% | 328,158 | 248.00K |
| 154 | ORIC | ORIC Pharmaceuticals, Inc. | 802.33M | 5.87% | 646,425 | - |
| 155 | WVE | Wave Life Sciences Ltd. | 799.76M | 3.65% | 421,593 | 112.91M |
| 156 | RAPP | Rapport Therapeutics, Inc. | 791.02M | 3.78% | 49,201 | - |
| 157 | ZYME | Zymeworks Inc. | 760.08M | 1.13% | 242,420 | 50.46M |
| 158 | TVTX | Travere Therapeutics, Inc. | 752.92M | 1.23% | 649,913 | 183.23M |
| 159 | ABVX | Abivax SA | 750.33M | 0.34% | 57,230 | 5.13M |
| 160 | AVBP | ArriVent BioPharma, Inc. | 749.59M | 5.87% | 73,817 | - |
| 161 | SRRK | Scholar Rock Holding Corporation | 740.12M | -1.80% | 629,986 | - |
| 162 | ABUS | Arbutus Biopharma Corporation | 736.00M | -0.51% | 717,350 | 12.99M |
| 163 | SVRA | Savara Inc. | 733.38M | -2.62% | 601,688 | - |
| 164 | SAVA | Cassava Sciences, Inc. | 715.80M | 17.02% | 3,634,489 | - |
| 165 | REPL | Replimune Group, Inc. | 707.13M | -1.24% | 522,952 | - |
| 166 | RGNX | REGENXBIO Inc. | 705.84M | -0.42% | 303,109 | 86.73M |
| 167 | ALMS | Alumis Inc. | 704.62M | -2.72% | 83,936 | - |
| 168 | PROK | ProKidney Corp. | 693.64M | 2.08% | 696,726 | - |
| 169 | SLRN | Acelyrin, Inc. | 693.19M | 4.01% | 1,591,722 | - |
| 170 | PHAT | Phathom Pharmaceuticals, Inc. | 687.20M | 4.08% | 855,753 | 2.59M |
| 171 | EXAI | Exscientia plc | 678.20M | 2.87% | 314,032 | 25.14M |
| 172 | MNMD | Mind Medicine (MindMed) Inc. | 677.15M | -0.27% | 741,819 | - |
| 173 | PRME | Prime Medicine, Inc. | 673.37M | -0.71% | 492,456 | 591.00K |
| 174 | URGN | UroGen Pharma Ltd. | 673.13M | -0.06% | 306,125 | 84.30M |
| 175 | MLYS | Mineralys Therapeutics, Inc. | 667.77M | -0.15% | 122,566 | - |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 664.63M | 4.16% | 1,336,424 | 174.50M |
| 177 | SAGE | Sage Therapeutics, Inc. | 661.40M | 4.97% | 926,086 | 91.06M |
| 178 | IGMS | IGM Biosciences, Inc. | 659.88M | -7.60% | 349,021 | 2.11M |
| 179 | ANNX | Annexon, Inc. | 657.78M | 1.05% | 1,158,425 | - |
| 180 | CELC | Celcuity Inc. | 657.44M | -2.19% | 366,498 | - |
| 181 | ATXS | Astria Therapeutics, Inc. | 655.11M | -0.17% | 253,815 | - |
| 182 | CDMO | Avid Bioservices, Inc. | 650.43M | -0.87% | 922,319 | 139.91M |
| 183 | GHRS | GH Research PLC | 649.83M | 5.76% | 46,357 | - |
| 184 | ARCT | Arcturus Therapeutics Holdings Inc. | 648.25M | 4.74% | 340,105 | 124.53M |
| 185 | TRDA | Entrada Therapeutics, Inc. | 639.31M | 0.70% | 78,615 | 162.87M |
| 186 | KALV | KalVista Pharmaceuticals, Inc. | 632.06M | 2.78% | 214,795 | - |
| 187 | ALLO | Allogene Therapeutics, Inc. | 626.35M | 3.09% | 1,534,255 | 65.00K |
| 188 | ALEC | Alector, Inc. | 625.54M | - | 396,412 | 96.41M |
| 189 | ITOS | iTeos Therapeutics, Inc. | 621.68M | 2.99% | 169,951 | - |
| 190 | VERV | Verve Therapeutics, Inc. | 621.34M | -1.07% | 846,336 | 16.05M |
| 191 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 620.47M | 4.71% | 226,885 | - |
| 192 | FATE | Fate Therapeutics, Inc. | 619.25M | 0.74% | 1,405,379 | 6.48M |
| 193 | LENZ | LENZ Therapeutics, Inc. | 612.06M | -0.42% | 61,250 | - |
| 194 | LRMR | Larimar Therapeutics, Inc. | 607.40M | 1.06% | 251,564 | - |
| 195 | PEPG | PepGen Inc. | 601.34M | 2.94% | 122,858 | - |
| 196 | APLT | Applied Therapeutics, Inc. | 596.47M | 0.38% | 323,122 | -477.00K |
| 197 | MREO | Mereo BioPharma Group plc | 582.82M | 1.84% | 468,515 | - |
| 198 | TERN | Terns Pharmaceuticals, Inc. | 582.74M | 2.50% | 561,600 | - |
| 199 | NGNE | Neurogene Inc. | 581.91M | 4.99% | 184,678 | - |
| 200 | ELYM | Eliem Therapeutics, Inc. | 577.69M | -2.81% | 382,222 | - |
| 201 | AVXL | Anavex Life Sciences Corp. | 570.48M | -1.46% | 1,353,583 | - |
| 202 | OABI | OmniAb, Inc. | 566.89M | 0.83% | 387,163 | 21.05M |
| 203 | FULC | Fulcrum Therapeutics, Inc. | 551.92M | 2.78% | 394,984 | 2.51M |
| 204 | YMAB | Y-mAbs Therapeutics, Inc. | 549.85M | 1.62% | 121,408 | 84.50M |
| 205 | PHAR | Pharming Group N.V. | 542.00M | -6.00% | 3,030 | 280.83M |
| 206 | CTNM | Contineum Therapeutics, Inc. | 540.19M | -0.24% | 31,089 | 50.00M |
| 207 | PRTC | PureTech Health plc | 538.90M | 2.09% | 1,708 | 3.33M |
| 208 | AURA | Aura Biosciences, Inc. | 513.27M | 0.88% | 145,983 | - |
| 209 | THRD | Third Harmonic Bio, Inc. | 509.82M | -0.88% | 45,397 | - |
| 210 | ABSI | Absci Corporation | 506.62M | 2.28% | 734,380 | 5.35M |
| 211 | EYPT | EyePoint Pharmaceuticals, Inc. | 505.74M | 2.64% | 358,515 | 50.02M |
| 212 | VALN | Valneva SE | 504.43M | -0.07% | 1,825 | 166.26M |
| 213 | VYGR | Voyager Therapeutics, Inc. | 504.23M | 0.87% | 338,145 | 119.04M |
| 214 | TBPH | Theravance Biopharma, Inc. | 498.49M | 0.39% | 218,575 | 61.51M |
| 215 | NKTX | Nkarta, Inc. | 496.09M | 1.88% | 408,167 | - |
| 216 | KRRO | Korro Bio, Inc. | 486.65M | 0.36% | 92,705 | - |
| 217 | OCS | Oculis Holding AG | 484.76M | 1.13% | 5,931 | 995.46K |
| 218 | ALT | Altimmune, Inc. | 478.59M | 0.90% | 2,147,029 | 410.00K |
| 219 | EDIT | Editas Medicine, Inc. | 464.64M | 1.44% | 1,015,171 | 69.41M |
| 220 | TSHA | Taysha Gene Therapies, Inc. | 463.17M | 1.32% | 1,073,073 | 14.16M |
| 221 | TRML | Tourmaline Bio, Inc. | 460.35M | 4.85% | 172,327 | - |
| 222 | HRTX | Heron Therapeutics, Inc. | 459.49M | -1.61% | 1,684,352 | 132.10M |
| 223 | CCCC | C4 Therapeutics, Inc. | 447.24M | 0.93% | 1,353,957 | 20.04M |
| 224 | QTTB | Q32 Bio Inc. | 432.66M | -5.53% | 170,917 | 354.00K |
| 225 | KYTX | Kyverna Therapeutics, Inc. | 424.25M | 10.56% | 294,923 | - |
| 226 | PGEN | Precigen, Inc. | 424.07M | 1.20% | 557,679 | 5.44M |
| 227 | OCGN | Ocugen, Inc. | 422.06M | 0.61% | 2,331,495 | 7.05M |
| 228 | LYEL | Lyell Immunopharma, Inc. | 418.10M | 0.61% | 355,696 | 68.00K |
| 229 | RVNC | Revance Therapeutics, Inc. | 409.44M | 4.26% | 1,740,201 | 236.65M |
| 230 | QURE | uniQure N.V. | 404.66M | -2.74% | 723,071 | 19.00M |
| 231 | ANL | Adlai Nortye Ltd. | 398.58M | 2.68% | 2,229 | 5.00M |
| 232 | ENGN | enGene Holdings Inc. | 397.50M | - | 101,175 | - |
| 233 | ACIU | AC Immune SA | 387.86M | - | 199,262 | 16.82M |
| 234 | XERS | Xeris Biopharma Holdings, Inc. | 386.95M | 2.15% | 1,221,660 | 171.36M |
| 235 | ANRO | Alto Neuroscience, Inc. | 386.05M | -0.90% | 74,699 | - |
| 236 | TCRX | TScan Therapeutics, Inc. | 384.31M | 1.25% | 209,519 | 14.81M |
| 237 | PSTX | Poseida Therapeutics, Inc. | 382.98M | 9.42% | 723,171 | 82.50M |
| 238 | LXEO | Lexeo Therapeutics, Inc. | 378.87M | -2.46% | 294,685 | - |
| 239 | FHTX | Foghorn Therapeutics Inc. | 374.02M | 3.68% | 88,993 | 33.90M |
| 240 | STRO | Sutro Biopharma, Inc. | 367.26M | 4.78% | 585,776 | 154.07M |
| 241 | NAUT | Nautilus Biotechnology, Inc. | 365.77M | 1.39% | 55,139 | - |
| 242 | INZY | Inozyme Pharma, Inc. | 360.62M | 0.69% | 185,347 | - |
| 243 | VNDA | Vanda Pharmaceuticals Inc. | 359.67M | 0.49% | 347,739 | 177.60M |
| 244 | SLDB | Solid Biosciences Inc. | 356.54M | 2.65% | 248,315 | - |
| 245 | ADAP | Adaptimmune Therapeutics plc | 355.14M | 6.92% | 1,922,977 | 18.36M |
| 246 | RNAC | Cartesian Therapeutics, Inc. | 353.83M | 5.49% | 53,993 | 25.91M |
| 247 | ADCT | ADC Therapeutics SA | 349.30M | -4.97% | 432,775 | 68.62M |
| 248 | BDTX | Black Diamond Therapeutics, Inc. | 348.77M | -0.48% | 209,659 | - |
| 249 | MGNX | MacroGenics, Inc. | 347.62M | 0.91% | 624,505 | 43.36M |
| 250 | CABA | Cabaletta Bio, Inc. | 347.11M | 6.52% | 589,822 | - |
| 251 | XOMA | XOMA Corporation | 340.31M | 1.11% | 35,331 | 5.81M |
| 252 | AVIR | Atea Pharmaceuticals, Inc. | 330.15M | 0.51% | 181,177 | - |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 328.70M | 1.24% | 90,286 | 72.88M |
| 254 | MGTX | MeiraGTx Holdings plc | 325.39M | -0.59% | 120,085 | 697.00K |
| 255 | OPT | Opthea Limited | 325.06M | 0.90% | 14,574 | 385.28K |
| 256 | PRLD | Prelude Therapeutics Incorporated | 318.04M | -3.34% | 35,058 | - |
| 257 | ZNTL | Zentalis Pharmaceuticals, Inc. | 317.43M | 2.52% | 431,077 | 40.56M |
| 258 | ALXO | ALX Oncology Holdings Inc. | 315.21M | -0.82% | 724,265 | - |
| 259 | JSPR | Jasper Therapeutics, Inc. | 310.61M | -3.15% | 193,960 | - |
| 260 | VRCA | Verrica Pharmaceuticals Inc. | 307.12M | -0.14% | 142,079 | 8.91M |
| 261 | TNYA | Tenaya Therapeutics, Inc. | 304.65M | -2.76% | 305,757 | - |
| 262 | OMER | Omeros Corporation | 302.47M | -1.14% | 239,447 | - |
| 263 | AKBA | Akebia Therapeutics, Inc. | 301.82M | -2.70% | 1,108,454 | 187.23M |
| 264 | DSGN | Design Therapeutics, Inc. | 296.60M | 7.14% | 227,274 | - |
| 265 | INO | Inovio Pharmaceuticals, Inc. | 293.31M | 3.38% | 573,266 | 717.07K |
| 266 | GLUE | Monte Rosa Therapeutics, Inc. | 285.57M | - | 201,594 | 1.06M |
| 267 | IMMP | Immutep Limited | 274.10M | 1.88% | 101,840 | 4.58M |
| 268 | ARTV | Artiva Biotherapeutics, Inc. | 273.64M | 0.76% | 212,935 | 32.75M |
| 269 | ACRV | Acrivon Therapeutics, Inc. | 273.57M | 5.85% | 53,377 | - |
| 270 | OBIO | Orchestra BioMed Holdings, Inc. | 269.13M | -6.70% | 128,813 | 2.22M |
| 271 | ATAI | Atai Life Sciences N.V. | 266.18M | 0.63% | 425,012 | 277.00K |
| 272 | CDXS | Codexis, Inc. | 261.06M | 1.37% | 456,110 | 74.23M |
| 273 | ZVRA | Zevra Therapeutics, Inc. | 260.33M | -0.16% | 604,789 | 28.01M |
| 274 | TECX | Tectonic Therapeutic Inc | 259.91M | 3.76% | 28,192 | - |
| 275 | MRSN | Mersana Therapeutics, Inc. | 256.96M | 6.06% | 1,066,409 | 38.30M |
| 276 | CBUS | Cibus, Inc. | 255.96M | -1.20% | 60,129 | 2.32M |
| 277 | NKTR | Nektar Therapeutics | 253.95M | 0.73% | 912,286 | 90.17M |
| 278 | GOSS | Gossamer Bio, Inc. | 253.37M | 2.75% | 702,690 | - |
| 279 | CRMD | CorMedix Inc. | 249.52M | -3.61% | 353,007 | - |
| 280 | ZURA | Zura Bio Limited | 247.97M | 3.18% | 257,610 | - |
| 281 | ALDX | Aldeyra Therapeutics, Inc. | 246.57M | 1.47% | 190,380 | - |
| 282 | TSVT | 2seventy bio, Inc. | 246.23M | 4.81% | 329,499 | 71.20M |
| 283 | NBTX | Nanobiotix S.A. | 243.09M | -4.62% | 854 | 40.23M |
| 284 | RZLT | Rezolute, Inc. | 240.49M | - | 200,776 | - |
| 285 | EPIX | ESSA Pharma Inc. | 236.90M | -1.48% | 28,883 | - |
| 286 | BLUE | bluebird bio, Inc. | 235.15M | 1.67% | 3,105,684 | 21.73M |
| 287 | GBIO | Generation Bio Co. | 233.52M | 2.63% | 66,324 | 9.96M |
| 288 | ATNM | Actinium Pharmaceuticals, Inc. | 232.91M | -1.01% | 429,309 | 81.00K |
| 289 | TRVI | Trevi Therapeutics, Inc. | 228.91M | 2.52% | 144,671 | - |
| 290 | PYXS | Pyxis Oncology, Inc. | 228.49M | 0.78% | 314,533 | 16.15M |
| 291 | CRBU | Caribou Biosciences, Inc. | 224.89M | 2.05% | 1,133,466 | 33.40M |
| 292 | XBIT | XBiotech Inc. | 220.51M | 3.13% | 84,087 | - |
| 293 | CYBN | Cybin Inc. | 217.96M | 0.53% | 2,053,473 | - |
| 294 | IPSC | Century Therapeutics, Inc. | 211.25M | 5.04% | 151,063 | 1.37M |
| 295 | MOLN | Molecular Partners AG | 210.73M | 9.06% | 25,055 | 7.64M |
| 296 | STTK | Shattuck Labs, Inc. | 209.70M | -0.45% | 162,738 | 2.72M |
| 297 | ABOS | Acumen Pharmaceuticals, Inc. | 209.08M | 2.05% | 444,678 | - |
| 298 | ABEO | Abeona Therapeutics Inc. | 208.91M | 1.39% | 240,914 | 3.50M |
| 299 | GLSI | Greenwich LifeSciences, Inc. | 208.27M | -2.71% | 34,028 | - |
| 300 | VTYX | Ventyx Biosciences, Inc. | 207.97M | 1.72% | 579,043 | - |
| 301 | GTHX | G1 Therapeutics, Inc. | 204.42M | -1.01% | 486,891 | 84.04M |
| 302 | GUTS | Fractyl Health, Inc. | 200.69M | 3.71% | 77,690 | 148.00K |
| 303 | OTLK | Outlook Therapeutics, Inc. | 200.35M | 2.64% | 298,456 | - |
| 304 | MCRB | Seres Therapeutics, Inc. | 199.91M | -2.94% | 2,216,568 | 126.85M |
| 305 | GNFT | Genfit S.A. | 199.53M | -3.48% | 19,890 | 42.42M |
| 306 | CADL | Candel Therapeutics, Inc. | 199.37M | 2.92% | 167,158 | - |
| 307 | BMEA | Biomea Fusion, Inc. | 199.13M | 1.47% | 312,139 | - |
| 308 | INBX | Inhibrx, Inc. | 198.75M | 2.23% | 24,200 | - |
| 309 | CHRS | Coherus BioSciences, Inc. | 197.33M | 8.86% | 1,314,290 | 301.87M |
| 310 | RENB | Renovaro Biosciences Inc. | 193.23M | 4.80% | 229,703 | - |
| 311 | LCTX | Lineage Cell Therapeutics, Inc. | 192.60M | -1.92% | 467,530 | 8.00M |
| 312 | RIGL | Rigel Pharmaceuticals, Inc. | 188.75M | -1.38% | 58,144 | 120.35M |
| 313 | CNTX | Context Therapeutics Inc. | 187.50M | 2.46% | 98,383 | - |
| 314 | ATOS | Atossa Therapeutics, Inc. | 184.86M | 4.26% | 880,744 | - |
| 315 | PBYI | Puma Biotechnology, Inc. | 184.75M | -2.79% | 357,108 | 226.63M |
| 316 | MDWD | MediWound Ltd. | 183.81M | 2.22% | 28,708 | 19.85M |
| 317 | FBLG | FibroBiologics, Inc. | 183.24M | 7.55% | 146,480 | - |
| 318 | SGMO | Sangamo Therapeutics, Inc. | 179.48M | 28.71% | 123,118,826 | 18.76M |
| 319 | SCPH | scPharmaceuticals Inc. | 178.11M | -0.80% | 146,208 | 17.63M |
| 320 | FENC | Fennec Pharmaceuticals Inc. | 177.91M | -1.51% | 95,194 | 44.95M |
| 321 | VIGL | Vigil Neuroscience, Inc. | 174.39M | 1.09% | 348,237 | - |
| 322 | CTXR | Citius Pharmaceuticals, Inc. | 173.45M | 3.13% | 1,021,632 | - |
| 323 | SKYE | Skye Bioscience, Inc. | 172.90M | 4.41% | 190,990 | - |
| 324 | IPHA | Innate Pharma S.A. | 172.42M | -0.47% | 10,088 | 68.49M |
| 325 | KOD | Kodiak Sciences Inc. | 170.74M | 0.93% | 133,287 | - |
| 326 | INMB | INmune Bio, Inc. | 169.73M | 1.30% | 133,605 | 131.00K |
| 327 | ADVM | Adverum Biotechnologies, Inc. | 169.58M | 0.99% | 259,949 | - |
| 328 | ACHV | Achieve Life Sciences, Inc. | 169.13M | 0.72% | 59,398 | - |
| 329 | MGX | Metagenomi, Inc. | 167.46M | -4.28% | 44,815 | 47.26M |
| 330 | RPTX | Repare Therapeutics Inc. | 167.23M | 1.03% | 97,555 | 97.86M |
| 331 | SYRS | Syros Pharmaceuticals, Inc. | 166.25M | 2.98% | 86,652 | 6.98M |
| 332 | CRVS | Corvus Pharmaceuticals, Inc. | 161.38M | 11.69% | 405,002 | - |
| 333 | ELEV | Elevation Oncology, Inc. | 160.09M | 1.38% | 188,237 | - |
| 334 | GALT | Galectin Therapeutics Inc. | 159.10M | 0.39% | 52,805 | - |
| 335 | VXRT | Vaxart, Inc. | 158.70M | 2.78% | 1,207,271 | 8.89M |
| 336 | CGEN | Compugen Ltd. | 158.47M | 0.57% | 112,207 | - |
| 337 | IVVD | Invivyd, Inc. | 157.50M | 2.33% | 170,598 | - |
| 338 | RANI | Rani Therapeutics Holdings, Inc. | 155.93M | 2.09% | 46,910 | - |
| 339 | DMAC | DiaMedica Therapeutics Inc. | 155.58M | -1.36% | 27,892 | - |
| 340 | PRQR | ProQR Therapeutics N.V. | 153.52M | -0.27% | 19,699 | 14.66M |
| 341 | ATYR | aTyr Pharma, Inc. | 153.20M | -0.45% | 934,869 | 588.00K |
| 342 | DRTS | Alpha Tau Medical Ltd. | 148.67M | -1.18% | 5,601 | - |
| 343 | CMPX | Compass Therapeutics, Inc. | 148.60M | 2.86% | 635,138 | - |
| 344 | XFOR | X4 Pharmaceuticals, Inc. | 144.76M | -0.32% | 1,053,775 | - |
| 345 | PDSB | PDS Biotechnology Corporation | 142.32M | -1.52% | 141,705 | - |
| 346 | CAPR | Capricor Therapeutics, Inc. | 139.75M | -1.35% | 271,609 | 27.10M |
| 347 | VERU | Veru Inc. | 138.85M | 0.05% | 426,258 | 13.48M |
| 348 | AGEN | Agenus Inc. | 137.76M | 9.97% | 758,943 | 161.42M |
| 349 | CLLS | Cellectis S.A. | 135.66M | 12.20% | 398,878 | 12.13M |
| 350 | SEER | Seer, Inc. | 134.42M | 0.49% | 375,481 | 15.67M |
| 351 | AMLX | Amylyx Pharmaceuticals, Inc. | 133.97M | 2.60% | 808,253 | 398.00M |
| 352 | ACET | Adicet Bio, Inc. | 130.66M | 5.30% | 986,123 | - |
| 353 | IMUX | Immunic, Inc. | 130.61M | 4.32% | 199,381 | - |
| 354 | IVA | Inventiva S.A. | 127.41M | -1.75% | 28,047 | 25.74M |
| 355 | NVCT | Nuvectis Pharma, Inc. | 127.39M | 4.83% | 20,097 | - |
| 356 | ATHA | Athira Pharma, Inc. | 126.87M | -0.30% | 41,338 | - |
| 357 | ANVS | Annovis Bio, Inc. | 122.44M | 4.68% | 369,655 | - |
| 358 | KPTI | Karyopharm Therapeutics Inc. | 120.94M | 1.06% | 1,670,654 | 140.46M |
| 359 | HOWL | Werewolf Therapeutics, Inc. | 118.63M | -0.36% | 163,490 | 16.22M |
| 360 | RLMD | Relmada Therapeutics, Inc. | 118.58M | -2.96% | 47,699 | - |
| 361 | CTMX | CytomX Therapeutics, Inc. | 116.88M | 5.63% | 572,088 | 119.18M |
| 362 | RAPT | RAPT Therapeutics, Inc. | 116.58M | 7.05% | 179,537 | - |
| 363 | RGLS | Regulus Therapeutics Inc. | 116.53M | 1.14% | 1,503,680 | - |
| 364 | CRVO | CervoMed Inc. | 115.80M | -2.37% | 41,131 | 6.36M |
| 365 | FGEN | FibroGen, Inc. | 115.39M | -5.69% | 3,070,370 | 167.49M |
| 366 | TELO | Telomir Pharmaceuticals, Inc. | 114.89M | -2.27% | 32,154 | - |
| 367 | TVGN | Tevogen Bio Holdings Inc. | 114.80M | -1.45% | 109,884 | - |
| 368 | ELDN | Eledon Pharmaceuticals, Inc. | 113.59M | -1.67% | 52,065 | - |
| 369 | COYA | Coya Therapeutics, Inc. | 111.88M | -0.14% | 41,855 | 6.13M |
| 370 | ADAG | Adagene Inc. | 111.56M | -0.40% | 5,787 | 815.75K |
| 371 | IMAB | I-Mab | 108.73M | -2.16% | 300,488 | 3.90M |
| 372 | OMGA | Omega Therapeutics, Inc. | 105.90M | 3.78% | 141,660 | 4.94M |
| 373 | ORMP | Oramed Pharmaceuticals Inc. | 105.64M | 2.36% | 56,171 | 674.00K |
| 374 | ARMP | Armata Pharmaceuticals, Inc. | 105.21M | -4.66% | 6,963 | 4.70M |
| 375 | CRDF | Cardiff Oncology, Inc. | 104.66M | -1.06% | 368,602 | 610.00K |
| 376 | SGMT | Sagimet Biosciences Inc. | 103.95M | 0.59% | 239,127 | 2.00M |
| 377 | AEON | AEON Biopharma, Inc. | 102.89M | -10.24% | 389,687 | - |
| 378 | TLSA | Tiziana Life Sciences Ltd | 102.06M | 2.80% | 170,089 | - |
| 379 | VTGN | VistaGen Therapeutics, Inc. | 99.56M | 1.10% | 63,963 | 1.06M |
| 380 | ANIX | Anixa Biosciences, Inc. | 97.62M | 5.54% | 140,725 | - |
| 381 | CKPT | Checkpoint Therapeutics, Inc. | 96.07M | -3.38% | 471,043 | 68.00K |
| 382 | CGTX | Cognition Therapeutics, Inc. | 94.94M | 12.86% | 881,308 | - |
| 383 | HLVX | HilleVax, Inc. | 93.97M | 1.07% | 602,783 | - |
| 384 | CDTX | Cidara Therapeutics, Inc. | 93.19M | 10.79% | 70,695 | 46.38M |
| 385 | EPRX | Eupraxia Pharmaceuticals Inc. | 92.97M | -2.25% | 7,947 | - |
| 386 | ASMB | Assembly Biosciences, Inc. | 92.12M | 0.67% | 6,147 | - |
| 387 | ALVR | AlloVir, Inc. | 90.42M | 2.24% | 52,046 | - |
| 388 | IFRX | InflaRx N.V. | 90.09M | - | 87,646 | 107.75K |
| 389 | LSB | LakeShore Biopharma Co., Ltd | 89.93M | 2.00% | 14,725 | - |
| 390 | DBVT | DBV Technologies S.A. | 89.44M | -5.95% | 15,921 | 14.94M |
| 391 | SER | Serina Therapeutics Inc | 88.85M | 8.10% | 12,255 | 3.15M |
| 392 | EYEN | Eyenovia, Inc. | 88.48M | - | 1,087,617 | 8.78K |
| 393 | CASI | CASI Pharmaceuticals, Inc. | 88.45M | -0.38% | 18,787 | 33.88M |
| 394 | BNTC | Benitec Biopharma Inc. | 88.05M | 3.02% | 13,066 | 7.00K |
| 395 | CLSD | Clearside Biomedical, Inc. | 87.44M | 3.54% | 296,165 | 8.45M |
| 396 | PMVP | PMV Pharmaceuticals, Inc. | 86.94M | 2.42% | 382,609 | - |
| 397 | PLX | Protalix BioTherapeutics, Inc. | 85.05M | 0.87% | 102,382 | 59.65M |
| 398 | IOBT | IO Biotech, Inc. | 84.99M | -3.01% | 115,895 | - |
| 399 | LPTX | Leap Therapeutics, Inc. | 84.18M | 1.38% | 75,734 | - |
| 400 | NTRB | Nutriband Inc. | 83.43M | -10.74% | 51,615 | 2.02M |
| 401 | BOLD | Boundless Bio, Inc. | 82.56M | -0.80% | 103,923 | - |
| 402 | CLRB | Cellectar Biosciences, Inc. | 82.09M | -3.17% | 566,839 | - |
| 403 | IKNA | Ikena Oncology, Inc. | 82.04M | 1.19% | 114,302 | 3.85M |
| 404 | TIL | Instil Bio, Inc. | 81.49M | -0.16% | 3,998 | - |
| 405 | ALLK | Allakos Inc. | 81.03M | 5.79% | 206,953 | - |
| 406 | MIST | Milestone Pharmaceuticals Inc. | 80.44M | 1.00% | 37,219 | - |
| 407 | ESLA | Estrella Immunopharma, Inc. | 80.39M | 27.75% | 3,941,938 | - |
| 408 | ANTX | AN2 Therapeutics, Inc. | 79.94M | 1.52% | 38,870 | - |
| 409 | CMRX | Chimerix, Inc. | 79.77M | 0.53% | 144,869 | 41.00K |
| 410 | KRON | Kronos Bio, Inc. | 79.32M | -1.49% | 60,769 | 7.59M |
| 411 | BYSI | BeyondSpring Inc. | 79.19M | -5.07% | 13,096 | 1.75M |
| 412 | ONCY | Oncolytics Biotech Inc. | 78.89M | - | 94,695 | - |
| 413 | MRNS | Marinus Pharmaceuticals, Inc. | 78.55M | 1.06% | 166,495 | 28.29M |
| 414 | AFMD | Affimed N.V. | 77.96M | 0.39% | 93,969 | 4.26M |
| 415 | BCAB | BioAtla, Inc. | 77.95M | -4.71% | 413,436 | - |
| 416 | SPRO | Spero Therapeutics, Inc. | 77.47M | 1.41% | 38,465 | 110.98M |
| 417 | GNTA | Genenta Science S.p.A. | 76.33M | 2.14% | 14,078 | - |
| 418 | GNLX | Genelux Corporation | 75.23M | 14.06% | 150,781 | 8.00K |
| 419 | OVID | Ovid Therapeutics Inc. | 75.20M | - | 195,854 | 473.54K |
| 420 | VSTM | Verastem, Inc. | 74.96M | -0.34% | 845,122 | - |
| 421 | MAIA | MAIA Biotechnology, Inc. | 72.28M | -2.65% | 100,546 | - |
| 422 | CVM | CEL-SCI Corporation | 70.95M | 8.26% | 58,189,490 | - |
| 423 | GRTS | Gritstone bio, Inc. | 70.84M | -0.65% | 570,335 | 15.65M |
| 424 | DTIL | Precision BioSciences, Inc. | 69.95M | -0.69% | 16,788 | 57.53M |
| 425 | CNTB | Connect Biopharma Holdings Limited | 68.88M | -4.41% | 20,539 | - |
| 426 | VANI | Vivani Medical, Inc. | 68.72M | - | 66,489 | - |
| 427 | CELU | Celularity Inc. | 68.40M | 6.02% | 7,663 | 14.79M |
| 428 | SLS | SELLAS Life Sciences Group, Inc. | 67.57M | 0.86% | 304,450 | - |
| 429 | THTX | Theratechnologies Inc. | 66.90M | 1.04% | 53,575 | 60.71M |
| 430 | CSBR | Champions Oncology, Inc. | 66.61M | 4.38% | 3,432 | 50.16M |
| 431 | VOR | Vor Biopharma Inc. | 65.67M | 1.09% | 193,263 | - |
| 432 | BLRX | BioLineRx Ltd. | 64.58M | -3.71% | 484,052 | 11.66M |
| 433 | INTS | Intensity Therapeutics, Inc. | 64.45M | -0.42% | 9,775 | - |
| 434 | MNOV | MediciNova, Inc. | 64.25M | 0.77% | 7,999 | 1.00M |
| 435 | ENTX | Entera Bio Ltd. | 60.53M | -2.87% | 61,447 | - |
| 436 | HOOK | HOOKIPA Pharma Inc. | 59.38M | -2.69% | 11,117 | 53.55M |
| 437 | MURA | Mural Oncology plc | 59.23M | 1.16% | 87,474 | - |
| 438 | IMMX | Immix Biopharma, Inc. | 59.17M | 4.19% | 125,042 | - |
| 439 | TSBX | Turnstone Biologics Corp. | 58.98M | 2.41% | 22,022 | - |
| 440 | AVTE | Aerovate Therapeutics, Inc. | 57.93M | 4.69% | 1,396,660 | - |
| 441 | ANEB | Anebulo Pharmaceuticals, Inc. | 57.05M | - | 1,482 | - |
| 442 | PASG | Passage Bio, Inc. | 56.52M | 4.20% | 80,310 | - |
| 443 | RLYB | Rallybio Corporation | 56.37M | 2.26% | 46,114 | - |
| 444 | ALRN | Aileron Therapeutics, Inc. | 55.12M | 2.59% | 56,065 | - |
| 445 | CLGN | CollPlant Biotechnologies Ltd. | 54.75M | 0.63% | 4,187 | 10.62M |
| 446 | LVTX | LAVA Therapeutics N.V. | 54.42M | -1.90% | 21,726 | 13.63M |
| 447 | LEXX | Lexaria Bioscience Corp. | 53.44M | 9.39% | 201,411 | 376.85K |
| 448 | BRNS | Barinthus Biotherapeutics plc | 53.37M | -6.16% | 24,533 | 334.00K |
| 449 | OCUP | Ocuphire Pharma, Inc. | 53.14M | 0.49% | 51,634 | 19.01M |
| 450 | ELTX | Elicio Therapeutics, Inc. | 52.24M | -1.02% | 12,440 | - |
| 451 | OKYO | OKYO Pharma Limited | 51.94M | -0.66% | 28,641 | - |
| 452 | VTVT | vTv Therapeutics Inc. | 51.58M | 0.52% | 22,925 | 1.00M |
| 453 | RPHM | Reneo Pharmaceuticals, Inc. | 50.13M | 0.67% | 78,613 | - |
| 454 | ATRA | Atara Biotherapeutics, Inc. | 49.88M | 4.20% | 30,440 | 34.70M |
| 455 | LGVN | Longeveron Inc. | 49.40M | 13.16% | 2,905,206 | 978.00K |
| 456 | LTRN | Lantern Pharma Inc. | 49.28M | 0.88% | 22,712 | - |
| 457 | CARM | Carisma Therapeutics, Inc. | 49.02M | 9.26% | 168,741 | 15.07M |
| 458 | KZR | Kezar Life Sciences, Inc. | 48.63M | 1.47% | 132,484 | 7.00M |
| 459 | MRKR | Marker Therapeutics, Inc. | 48.61M | 3.44% | 15,629 | 3.32M |
| 460 | TARA | Protara Therapeutics, Inc. | 48.39M | 2.62% | 98,679 | - |
| 461 | FBIO | Fortress Biotech, Inc. | 45.93M | -13.46% | 510,208 | 85.11M |
| 462 | NXTC | NextCure, Inc. | 45.88M | 3.80% | 9,169 | - |
| 463 | ABIO | ARCA biopharma, Inc. | 45.55M | 2.28% | 122,420 | - |
| 464 | DYAI | Dyadic International, Inc. | 45.32M | 7.80% | 129,804 | 2.26M |
| 465 | OCEA | Ocean Biomedical, Inc. | 44.35M | 14.29% | 584,579 | - |
| 466 | BTAI | BioXcel Therapeutics, Inc. | 43.16M | -1.71% | 258,473 | 1.76M |
| 467 | MTNB | Matinas BioPharma Holdings, Inc. | 42.44M | -0.12% | 794,350 | - |
| 468 | CALC | CalciMedica, Inc. | 42.36M | 1.55% | 1,917 | - |
| 469 | ALGS | Aligos Therapeutics, Inc. | 40.50M | -0.02% | 55,025 | 13.79M |
| 470 | UNCY | Unicycive Therapeutics, Inc. | 39.16M | 3.86% | 1,865,069 | - |
| 471 | AADI | Aadi Bioscience, Inc. | 38.80M | -1.86% | 139,021 | 23.84M |
| 472 | MLEC | Moolec Science SA | 37.94M | - | 9,705 | 5.01M |
| 473 | TPST | Tempest Therapeutics, Inc. | 37.77M | -1.16% | 414,941 | - |
| 474 | XLO | Xilio Therapeutics, Inc. | 37.28M | -1.60% | 88,763 | - |
| 475 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 37.27M | -0.79% | 325,239 | - |
| 476 | INAB | IN8bio, Inc. | 37.02M | 3.22% | 54,000 | - |
| 477 | IMRX | Immuneering Corporation | 36.77M | 0.81% | 64,735 | - |
| 478 | ICU | SeaStar Medical Holding Corporation | 36.69M | 11.53% | 483,247 | - |
| 479 | ACXP | Acurx Pharmaceuticals, Inc. | 36.08M | 0.88% | 14,157 | - |
| 480 | CRIS | Curis, Inc. | 36.07M | 1.66% | 11,287 | 9.81M |
| 481 | NRBO | NeuroBo Pharmaceuticals, Inc. | 34.12M | 1.47% | 14,553 | - |
| 482 | IGC | IGC Pharma Inc | 33.96M | -0.24% | 87,750 | 1.35M |
| 483 | QNCX | Quince Therapeutics, Inc. | 33.95M | 0.73% | 38,508 | - |
| 484 | AKTX | Akari Therapeutics, Plc | 33.68M | 6.00% | 24,852 | - |
| 485 | ACHL | Achilles Therapeutics plc | 32.96M | 2.19% | 31,503 | - |
| 486 | CUE | Cue Biopharma, Inc. | 32.59M | -4.73% | 421,688 | 7.02M |
| 487 | ICCC | ImmuCell Corporation | 31.64M | -0.25% | 1,382 | 21.28M |
| 488 | INKT | MiNK Therapeutics, Inc. | 31.20M | -3.40% | 48,777 | - |
| 489 | NKGN | NKGen Biotech, Inc. | 30.93M | 4.35% | 264,878 | - |
| 490 | RNXT | RenovoRx, Inc. | 30.86M | 4.88% | 16,306 | - |
| 491 | DARE | Daré Bioscience, Inc. | 30.58M | 0.83% | 8,986 | 2.82M |
| 492 | PLUR | Pluri Inc. | 30.44M | -7.52% | 3,736 | 341.00K |
| 493 | VYNE | VYNE Therapeutics Inc. | 30.36M | -0.48% | 12,830 | 423.00K |
| 494 | PMN | ProMIS Neurosciences, Inc. | 30.34M | -24.88% | 6,623,058 | - |
| 495 | LPCN | Lipocine Inc. | 29.47M | -5.33% | 14,605 | 4.71M |
| 496 | EQ | Equillium, Inc. | 28.83M | 2.21% | 47,304 | 37.89M |
| 497 | BIVI | BioVie Inc. | 28.75M | 6.19% | 1,300,125 | - |
| 498 | BOLT | Bolt Biotherapeutics, Inc. | 28.60M | 1.90% | 138,005 | 11.32M |
| 499 | ENLV | Enlivex Therapeutics Ltd. | 28.39M | -2.11% | 82,855 | - |
| 500 | LSTA | Lisata Therapeutics, Inc. | 28.12M | -2.63% | 3,757 | - |
| 501 | BCLI | Brainstorm Cell Therapeutics Inc. | 27.98M | -3.93% | 134,890 | - |
| 502 | PTN | Palatin Technologies, Inc. | 27.43M | -6.08% | 66,628 | 5.90M |
| 503 | SRZN | Surrozen, Inc. | 27.41M | 0.47% | 3,195 | - |
| 504 | NNVC | NanoViricides, Inc. | 26.46M | 1.82% | 157,387 | - |
| 505 | EVGN | Evogene Ltd. | 26.11M | 6.20% | 55,197 | 9.19M |
| 506 | ACST | Acasti Pharma Inc. | 25.94M | -1.79% | 10,803 | - |
| 507 | SABS | SAB Biotherapeutics, Inc. | 25.84M | 1.45% | 2,989 | 2.60M |
| 508 | NRXP | NRx Pharmaceuticals, Inc. | 25.79M | 2.99% | 13,864 | - |
| 509 | ORGS | Orgenesis Inc. | 25.49M | -12.76% | 150,869 | 529.00K |
| 510 | UBX | Unity Biotechnology, Inc. | 24.68M | 2.08% | 31,152 | - |
| 511 | APLM | Apollomics, Inc. | 24.12M | 8.13% | 1,854,835 | - |
| 512 | BIOR | Biora Therapeutics, Inc. | 24.00M | 1.94% | 60,742 | 544.00K |
| 513 | MEIP | MEI Pharma, Inc. | 23.72M | 2.89% | 32,591 | 66.75M |
| 514 | HCWB | HCW Biologics Inc. | 22.69M | -0.17% | 8,688 | 1.16M |
| 515 | IPA | ImmunoPrecise Antibodies Ltd. | 22.63M | -1.73% | 85,886 | 17.67M |
| 516 | SPRB | Spruce Biosciences, Inc. | 22.47M | 0.24% | 116,457 | 10.13M |
| 517 | PIRS | Pieris Pharmaceuticals, Inc. | 22.46M | -1.73% | 83,965 | 40.93M |
| 518 | COCP | Cocrystal Pharma, Inc. | 22.38M | -0.90% | 9,620 | - |
| 519 | WENA | Anew Medical, Inc. | 22.24M | 2.74% | 202,236 | - |
| 520 | CANF | Can-Fite BioPharma Ltd. | 21.99M | 5.40% | 130,482 | 743.00K |
| 521 | APRE | Aprea Therapeutics, Inc. | 21.50M | 3.54% | 3,698 | 963.80K |
| 522 | NERV | Minerva Neurosciences, Inc. | 21.40M | -1.28% | 16,583 | - |
| 523 | NRXS | NeurAxis, Inc. | 21.21M | 1.92% | 1,466 | 2.30M |
| 524 | ONCT | Oncternal Therapeutics, Inc. | 20.98M | 5.35% | 1,114 | 1.15M |
| 525 | GDTC | CytoMed Therapeutics Limited | 20.89M | -9.05% | 43,048 | - |
| 526 | AIM | AIM ImmunoTech Inc. | 20.85M | 2.38% | 160,471 | 193.00K |
| 527 | ITRM | Iterum Therapeutics plc | 20.73M | - | 293,817 | - |
| 528 | CARA | Cara Therapeutics, Inc. | 20.36M | 2.00% | 510,472 | 16.94M |
| 529 | FBRX | Forte Biosciences, Inc. | 20.34M | -2.42% | 9,744 | - |
| 530 | VINC | Vincerx Pharma, Inc. | 20.18M | 3.66% | 108,293 | - |
| 531 | SYBX | Synlogic, Inc. | 19.55M | 3.73% | 1,863 | 3.21M |
| 532 | KALA | Kala Pharmaceuticals, Inc. | 19.45M | -5.39% | 32,721 | - |
| 533 | IBIO | iBio, Inc. | 19.40M | 0.45% | 23,180 | 50.00K |
| 534 | GANX | Gain Therapeutics, Inc. | 18.95M | 0.96% | 231,879 | - |
| 535 | VIRX | Viracta Therapeutics, Inc. | 18.86M | -1.09% | 85,776 | - |
| 536 | APM | Aptorum Group Limited | 18.81M | 2.30% | 5,071 | 431.38K |
| 537 | LYRA | Lyra Therapeutics, Inc. | 18.75M | -0.45% | 614,818 | 1.68M |
| 538 | CDT | Conduit Pharmaceuticals Inc. | 18.09M | 1.24% | 1,219,796 | - |
| 539 | INDP | Indaptus Therapeutics, Inc. | 17.55M | 20.20% | 7,285 | - |
| 540 | EDSA | Edesa Biotech, Inc. | 17.43M | 5.87% | 10,425 | - |
| 541 | CMMB | Chemomab Therapeutics Ltd. | 16.77M | 6.72% | 196,830 | - |
| 542 | PMCB | PharmaCyte Biotech, Inc. | 16.75M | 0.05% | 1,735 | - |
| 543 | SNSE | Sensei Biotherapeutics, Inc. | 16.57M | 1.92% | 12,953 | - |
| 544 | AEZS | Aeterna Zentaris Inc. | 16.38M | -2.80% | 1,664 | 2.37M |
| 545 | VBIV | VBI Vaccines Inc. | 16.06M | 3.67% | 95,521 | 9.41M |
| 546 | PHGE | BiomX Inc. | 15.62M | -1.84% | 138,415 | - |
| 547 | EVAX | Evaxion Biotech A/S | 15.58M | 3.09% | 11,277 | 73.00K |
| 548 | GLYC | GlycoMimetics, Inc. | 15.55M | 2.55% | 1,446,003 | 10.00K |
| 549 | GLTO | Galecto, Inc. | 15.54M | 3.37% | 58,282 | - |
| 550 | XTLB | XTL Biopharmaceuticals Ltd. | 15.25M | 4.20% | 6,813 | - |
| 551 | IMRN | Immuron Limited | 14.67M | 5.75% | 7,011 | 2.43M |
| 552 | LUMO | Lumos Pharma, Inc. | 14.61M | 16.99% | 106,450 | 1.53M |
| 553 | NRSN | NeuroSense Therapeutics Ltd. | 14.60M | -1.25% | 45,286 | - |
| 554 | ATHE | Alterity Therapeutics Limited | 14.28M | -1.25% | 6,528 | - |
| 555 | KPRX | Kiora Pharmaceuticals, Inc. | 13.96M | 0.21% | 6,743 | 16.00M |
| 556 | SLGL | Sol-Gel Technologies Ltd. | 13.96M | 11.33% | 1,384,638 | 1.72M |
| 557 | BCTX | BriaCell Therapeutics Corp. | 13.92M | -1.09% | 85,962 | - |
| 558 | PPBT | Purple Biotech Ltd. | 13.67M | 2.40% | 104,331 | - |
| 559 | KTRA | Kintara Therapeutics, Inc. | 13.54M | 12.71% | 2,306,536 | - |
| 560 | GOVX | GeoVax Labs, Inc. | 13.14M | 1.55% | 264,165 | - |
| 561 | MNPR | Monopar Therapeutics Inc. | 12.67M | 10.60% | 116,859 | - |
| 562 | MBIO | Mustang Bio, Inc. | 12.42M | 3.65% | 1,119,123 | - |
| 563 | ADXN | Addex Therapeutics Ltd | 12.07M | - | 8 | 1.57M |
| 564 | AVTX | Avalo Therapeutics, Inc. | 11.93M | -2.25% | 6,664 | 1.45M |
| 565 | IKT | Inhibikase Therapeutics, Inc. | 11.51M | 3.18% | 10,331 | 195.98K |
| 566 | BRTX | BioRestorative Therapies, Inc. | 10.97M | -4.79% | 46,249 | 149.50K |
| 567 | TRAW | Traws Pharma, Inc. | 10.88M | 5.52% | 28,222 | 226.00K |
| 568 | IMNN | Imunon, Inc. | 10.81M | -0.87% | 127,079 | - |
| 569 | DOMH | Dominari Holdings Inc. | 10.71M | -1.14% | 6,960 | 3.41M |
| 570 | PSTV | Plus Therapeutics, Inc. | 10.67M | 3.89% | 95,795 | 6.08M |
| 571 | VCNX | Vaccinex, Inc. | 10.65M | -2.61% | 62,980 | 124.00K |
| 572 | CDIO | Cardio Diagnostics Holdings, Inc. | 10.62M | 0.88% | 186,880 | 32.99K |
| 573 | SNTI | Senti Biosciences, Inc. | 10.29M | -3.02% | 32,932 | 1.28M |
| 574 | APTO | Aptose Biosciences Inc. | 10.29M | -2.91% | 94,828 | - |
| 575 | CLDI | Calidi Biotherapeutics, Inc. | 10.14M | -7.17% | 254,507 | - |
| 576 | ERNA | Eterna Therapeutics Inc. | 9.79M | 0.56% | 4,508 | 115.00K |
| 577 | COEP | Coeptis Therapeutics, Inc. | 9.65M | -2.80% | 162,338 | - |
| 578 | TNXP | Tonix Pharmaceuticals Holding Corp. | 9.60M | -5.09% | 1,816,732 | 10.25M |
| 579 | KZIA | Kazia Therapeutics Limited | 9.52M | -3.20% | 1,194,253 | 15.65K |
| 580 | ABVC | ABVC BioPharma, Inc. | 9.03M | 3.08% | 107,309 | 25.36K |
| 581 | NLSP | NLS Pharmaceutics AG | 8.87M | -2.14% | 446,473 | - |
| 582 | MTEM | Molecular Templates, Inc. | 8.76M | 1.46% | 2,946 | 31.76M |
| 583 | SILO | Silo Pharma, Inc. | 8.63M | 9.95% | 1,918,271 | 72.10K |
| 584 | NCNA | NuCana plc | 8.54M | 4.48% | 33,303 | - |
| 585 | ONVO | Organovo Holdings, Inc. | 8.47M | 2.70% | 65,194 | 109.00K |
| 586 | CYCN | Cyclerion Therapeutics, Inc. | 8.46M | 0.63% | 15,176 | - |
| 587 | CHRO | Chromocell Therapeutics Corporation | 8.42M | 8.91% | 88,055 | - |
| 588 | ELAB | Elevai Labs, Inc. | 8.36M | 5.99% | 81,035 | 2.18M |
| 589 | MBRX | Moleculin Biotech, Inc. | 8.14M | 3.80% | 9,387 | - |
| 590 | KA | Kineta, Inc. | 7.87M | -4.32% | 177,872 | 5.16M |
| 591 | AZTR | Azitra, Inc. | 7.85M | -9.65% | 2,137,868 | 572.70K |
| 592 | PULM | Pulmatrix, Inc. | 7.67M | 1.19% | 7,725 | 11.68M |
| 593 | BNOX | Bionomics Limited | 7.27M | -1.18% | 165,090 | 15.00K |
| 594 | CVKD | Cadrenal Therapeutics, Inc. | 7.15M | 2.09% | 49,107 | - |
| 595 | VRPX | Virpax Pharmaceuticals, Inc. | 6.64M | -8.61% | 547,136 | - |
| 596 | TENX | Tenax Therapeutics, Inc. | 6.64M | 2.11% | 1,715 | - |
| 597 | XBIO | Xenetic Biosciences, Inc. | 6.59M | 3.39% | 18,594 | 2.44M |
| 598 | JAGX | Jaguar Health, Inc. | 6.26M | -5.19% | 900,705 | 10.14M |
| 599 | VIRI | Virios Therapeutics, Inc. | 6.11M | -5.09% | 803,001 | - |
| 600 | NTBL | Notable Labs, Ltd. | 6.05M | 7.57% | 76,623 | 311.00K |
| 601 | TCRT | Alaunos Therapeutics, Inc. | 6.02M | -0.27% | 8,598 | 5.00K |
| 602 | GTBP | GT Biopharma, Inc. | 5.96M | 1.65% | 2,399 | - |
| 603 | OGEN | Oragenics, Inc. | 5.89M | 4.46% | 70,008 | 20.63K |
| 604 | TFFP | TFF Pharmaceuticals, Inc. | 5.81M | 1.70% | 9,801 | 885.72K |
| 605 | PYPD | PolyPid Ltd. | 5.72M | -1.14% | 388 | - |
| 606 | ALLR | Allarity Therapeutics, Inc. | 5.70M | 14.90% | 14,022,505 | - |
| 607 | CMND | Clearmind Medicine Inc. | 5.67M | 8.48% | 337,930 | - |
| 608 | BCDA | BioCardia, Inc. | 5.44M | 6.10% | 20,229 | 468.00K |
| 609 | DRUG | Bright Minds Biosciences Inc. | 5.36M | 1.69% | 9,966 | - |
| 610 | CERO | CERo Therapeutics Holdings, Inc. | 5.33M | 6.14% | 10,461,515 | - |
| 611 | KTTA | Pasithea Therapeutics Corp. | 5.27M | 10.75% | 2,749 | - |
| 612 | SNPX | Synaptogenix, Inc. | 5.24M | -0.48% | 41,678 | - |
| 613 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.22M | 0.43% | 9,056 | - |
| 614 | XRTX | XORTX Therapeutics Inc. | 5.08M | -3.28% | 62,250 | - |
| 615 | TTNP | Titan Pharmaceuticals, Inc. | 5.07M | -4.25% | 3,839 | 87.00K |
| 616 | WINT | Windtree Therapeutics, Inc. | 4.91M | 151.21% | 48,202,905 | - |
| 617 | CELZ | Creative Medical Technology Holdings, Inc. | 4.89M | 2.54% | 2,068 | 9.00K |
| 618 | TOVX | Theriva Biologics, Inc. | 4.79M | 0.73% | 43,085 | - |
| 619 | PCSA | Processa Pharmaceuticals, Inc. | 4.77M | 2.11% | 9,472 | - |
| 620 | HEPA | Hepion Pharmaceuticals, Inc. | 4.61M | 5.12% | 92,450 | - |
| 621 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 4.49M | -1.44% | 37,110 | 92.73K |
| 622 | SNGX | Soligenix, Inc. | 4.47M | 1.80% | 209,585 | 699.21K |
| 623 | HOTH | Hoth Therapeutics, Inc. | 4.47M | 3.05% | 923,159 | - |
| 624 | ADIL | Adial Pharmaceuticals, Inc. | 4.44M | -10.26% | 792,629 | - |
| 625 | ARTL | Artelo Biosciences, Inc. | 4.36M | -2.81% | 4,003 | - |
| 626 | XCUR | Exicure, Inc. | 4.15M | -4.00% | 1,049,966 | 500.00K |
| 627 | TRVN | Trevena, Inc. | 4.15M | -2.28% | 102,638 | 3.14M |
| 628 | PALI | Palisade Bio, Inc. | 3.99M | -0.96% | 10,113 | - |
| 629 | GNPX | Genprex, Inc. | 3.90M | -3.09% | 15,161 | - |
| 630 | PRTG | Portage Biotech Inc. | 3.87M | - | 165,639 | - |
| 631 | ONCO | Onconetix, Inc. | 3.85M | 7.20% | 5,146,689 | 758.90K |
| 632 | ENVB | Enveric Biosciences, Inc. | 3.74M | -0.15% | 309,949 | - |
| 633 | CING | Cingulate Inc. | 3.69M | -5.49% | 292,550 | - |
| 634 | BPTH | Bio-Path Holdings, Inc. | 3.68M | 4.00% | 13,130 | - |
| 635 | THAR | Tharimmune, Inc. | 3.55M | 2.24% | 19,382 | - |
| 636 | ENSC | Ensysce Biosciences, Inc. | 3.25M | 2.89% | 93,431 | - |
| 637 | VRAX | Virax Biolabs Group Limited | 3.24M | 15.38% | 232,664 | 79.30K |
| 638 | ZVSA | ZyVersa Therapeutics, Inc. | 3.21M | -0.26% | 29,317 | - |
| 639 | APVO | Aptevo Therapeutics Inc. | 3.17M | 1.03% | 461,901 | - |
| 640 | PTIX | Protagenic Therapeutics, Inc. | 3.12M | -4.68% | 5,469 | - |
| 641 | FRES | Fresh2 Group Limited | 3.08M | 2.43% | 15,918 | 2.35M |
| 642 | LIPO | Lipella Pharmaceuticals Inc. | 3.07M | 5.82% | 50,986 | 477.45K |
| 643 | CNSP | CNS Pharmaceuticals, Inc. | 3.07M | -5.31% | 335,445 | - |
| 644 | ALZN | Alzamend Neuro, Inc. | 3.04M | -2.04% | 26,563 | - |
| 645 | TCBP | TC Biopharm (Holdings) Plc | 2.88M | 9.62% | 41,701 | - |
| 646 | QLGN | Qualigen Therapeutics, Inc. | 2.72M | -5.50% | 887,957 | 1.63M |
| 647 | ADTX | Aditxt, Inc. | 2.69M | -2.17% | 183,428 | 506.44K |
| 648 | CYTO | Altamira Therapeutics Ltd. | 2.62M | -0.85% | 20,846 | - |
| 649 | REVB | Revelation Biosciences, Inc. | 2.60M | -1.85% | 19,255 | - |
| 650 | INM | InMed Pharmaceuticals Inc. | 2.57M | 3.77% | 2,890,702 | 5.63M |
| 651 | ATXI | Avenue Therapeutics, Inc. | 2.56M | -5.23% | 133,715 | - |
| 652 | NBY | NovaBay Pharmaceuticals, Inc. | 2.54M | -63.91% | 3,958,013 | 14.23M |
| 653 | CYCC | Cyclacel Pharmaceuticals, Inc. | 2.49M | -0.60% | 76,132 | 449.00K |
| 654 | SCNI | Scinai Immunotherapeutics Ltd. | 2.35M | 17.24% | 193,542 | - |
| 655 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.30M | 0.11% | 3,407,942 | 569.86K |
| 656 | ATNF | 180 Life Sciences Corp. | 2.23M | 0.44% | 30,999 | - |
| 657 | QNRX | Quoin Pharmaceuticals, Ltd. | 2.21M | -3.23% | 91,676 | - |
| 658 | RNAZ | TransCode Therapeutics, Inc. | 2.15M | -2.02% | 872,938 | - |
| 659 | PHIO | Phio Pharmaceuticals Corp. | 2.03M | 3.16% | 77,443 | - |
| 660 | ENTO | Entero Therapeutics, Inc. | 2.03M | -20.83% | 371,831 | - |
| 661 | SLRX | Salarius Pharmaceuticals, Inc. | 1.90M | -8.86% | 1,252,447 | - |
| 662 | GLMD | Galmed Pharmaceuticals Ltd. | 1.89M | 1.92% | 6,140 | - |
| 663 | DRMA | Dermata Therapeutics, Inc. | 1.57M | -12.02% | 383,471 | - |
| 664 | GRI | GRI Bio, Inc. | 1.29M | -0.79% | 457,280 | - |
| 665 | SEEL | Seelos Therapeutics, Inc. | 1.26M | -6.60% | 295,667 | 1.97M |
| 666 | SPRC | SciSparc Ltd. | 1.16M | -4.53% | 338,658 | 2.88M |
| 667 | BDRX | Biodexa Pharmaceuticals Plc | 181.64K | -4.12% | 268,048 | 482.28K |